HB
GSK icon

Horizon Bancorp’s GSK GSK Stock Holding History

Horizon Bancorp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
5,319
-221
-4% -$11.7K 0.13% 58
2026
Q1 		$306K Buy
5,540
+1,600
+41% +$86.7K 0.15% 48
2025
Q4 		$193K Sell
3,940
-2,095
-35% -$97.7K 0.09% 76
2025
Q3 		$261K Buy
6,035
+2,244
+59% +$87.7K 0.12% 61
2025
Q2 		$146K Sell
3,791
-104
-3% -$3.97K 0.07% 94
2025
Q1 		$151K Sell
3,895
-340
-8% -$12.4K 0.09% 73
2024
Q4 		$143K Sell
4,235
-134
-3% -$4.82K 0.07% 80
2024
Q3 		$179K Sell
4,369
-214
-5% -$8.76K 0.08% 73
2024
Q2 		$176K Buy
4,583
+551
+14% +$23.2K 0.08% 67
2024
Q1 		$173K Buy
4,032
+71
+2% +$2.93K 0.08% 72
2023
Q4 		$147K Buy
3,961
+323
+9% +$11.6K 0.07% 76
2023
Q3 		$132K Buy
3,638
+3,317
+1,033% +$118K 0.08% 67
2023
Q2 		$11K Buy
+321
New +$11.5K 0.01% 186
2020
Q2 		– Sell
-2,400
Closed -$114K – 253
2020
Q1 		$114K Buy
2,400
+1,960
+445% +$105K 0.18% 138
2019
Q4 		$26K Buy
+440
New +$24.5K 0.02% 216

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Horizon Bancorp's GSK Position: Q2 2026 in Review

Horizon Bancorp reduced its GSK (GSK) stake by 4% in Q2 2026, selling an estimated $11.7K and leaving 5,319 shares worth $279K. The position accounts for 0.13% of the portfolio, ranked #58.

Horizon Bancorp first reported a position in GSK in Q4 2019 and has held it in 15 quarters since. The position peaked at $306K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Horizon Bancorp held 5,319 shares of GSK worth $279K as of Q2 2026.
  • Horizon Bancorp sold 221 GSK shares in Q2 2026, an estimated $11.7K.
  • GSK made up 0.13% of Horizon Bancorp's portfolio in Q2 2026, its #58 holding.
  • Horizon Bancorp first reported a position in GSK in Q4 2019 and has held it in 15 quarters since.
  • Horizon Bancorp's GSK position peaked at $306K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Horizon Bancorp's 13F filing for Q2 2026, filed 4 Aug 2026.